Your browser doesn't support javascript.
loading
Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes.
Marti, G E; Zenger, V; Caproaso, N E; Brown, M; Washington, G C; Carter, P; Schechter, G; Noguchi, P.
  • Marti GE; Food and Drug Administration (FDA), Bethesda, Maryland.
Anal Quant Cytol Histol ; 11(5): 315-23, 1989 Oct.
Article en En | MEDLINE | ID: mdl-2803444
A flow cytometric analysis of lymphocytes in B-cell chronic lymphocytic leukemia (B-CLL) samples and in monocyte-depleted and T-cell-depleted normal peripheral blood (B-PBL) samples was undertaken using 129 reagents from the blind panel (BP) and 72 reagents from the cluster designation (CD) panel obtained from the Fourth International Leucocyte Differentiation Conference and Workshop, B-Cell Section. After determining the average mean channel fluorescence and the average percentage of positive cells for the B-CLL and the normal B-PBL preparations, a combined ratio and difference analysis was performed for each monoclonal antibody reactivity. This analysis confirmed the intense expression of class II antigens on B-CLL and the preferential expression of CD19, CD20, CD23 and CD24 antigens. In addition, three new clustered and three new unclustered antigens were also preferentially expressed on B-CLL lymphocytes. Cluster analysis of these differences suggests the existence of at least three overlapping immunophenotypic subpopulations, composed of CD19, CD20, CD21, CD22, CD23, CD24, CD75, CD76 and CDw78.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antígenos de Neoplasias Límite: Humans Idioma: En Año: 1989 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antígenos de Neoplasias Límite: Humans Idioma: En Año: 1989 Tipo del documento: Article